Minor Power Alley Stuff: Verona Pharma Shareholders Have Approved Rahway's ~$10 Billion Acquisition Offer -- Closing, Next, On October 7.

As expected, and at this point, immaterial to Merck. But it does build out the COPD franchise appreciably. [With my early July 2025 backgrounder on it, here.]

Here's the official notice (and again, we will be off-grid when it closes); do see here:

. . .On September 24, 2025, Verona Pharma‘s shareholders approved the acquisition by Merck & Co., Inc. through its subsidiary, Vol Holdings LLC, for $107 per American Depository Share, totaling approximately $10 billion.

The transaction, structured as a scheme of arrangement under English law, awaits the High Court of Justice’s sanction, with the effective date expected to be October 7, 2025, pending certain closing conditions. . . .

Now you know. Have a great weekend, one and all!

नमस्ते